This inventor holds 1 USPTO granted patent and 3 published patent applications. Top assignee: Dewpoint Therapeutics, Inc.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Adam Talbot and His Work on Beta-Catenin Modulators.
Introduction
Adam Talbot is an inventor based in Boston, Massachusetts, and is associated with Dewpoint Therapeutics, Inc. His patent work concerns compounds designed to modulate beta-catenin condensates, a research area with potential relevance to treating related diseases and conditions.
Latest Patents
Talbot is named on one patent: “Modulators of beta catenin and uses thereof.” The patent describes compounds of Formula I, or their pharmaceutically acceptable salts, for modulating beta-catenin condensates and potentially treating conditions associated with them. The supplied information lists 1 patent.
Career Highlights
Talbot’s listed invention reflects work at the intersection of therapeutic research and the study of cellular condensates. His association with Dewpoint Therapeutics connects his patent activity with the company’s research and development efforts.
Collaborations
Talbot’s listed coworker is Thomas Durand-Reville. Their association provides context for the collaborative environment surrounding this area of therapeutic research.
Conclusion
Adam Talbot’s patent on beta-catenin modulators highlights his contribution to research into compounds that may help address diseases associated with beta-catenin condensates.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile